§ 21–2A-07
Statutes in effect as of October 1, 2026.
Md. Code Ann., Health-Gen. § 21-2A-07 (2026)
Title 21. Food, Drugs, and Cosmetics
Subtitle 2A. Prescription Drug Monitoring Program
§ 21–2A-07LinkCopy Citation
(a)
There is a technical advisory committee to the Program.
(b)
The purpose of the technical advisory committee is to:
(1)
Review requests for information from the Program under § 21–2A–06(b)(3), (4), (5), (8), or (9) of this subtitle; and
(2)
Provide clinical guidance and interpretation to the Program regarding indications of possible misuse or abuse of a monitored prescription drug or a possible violation of law or a possible breach of professional standards by a prescriber or a dispenser under § 21–2A–06(c) and (d) of this subtitle.
(c)
The technical advisory committee consists of members appointed by the Secretary, including:
(1)
A board certified anesthesiologist licensed and practicing in the State, nominated by the Maryland Society of Anesthesiologists;
(2)
A certified addiction medicine specialist licensed and practicing in the State, nominated by the Maryland Society for Addiction Medicine;
(3)
A pharmacist licensed and practicing in the State;
(4)
A medical professional, licensed and practicing in the State, who is treating cancer patients;
(5)
A board certified physician specializing in the treatment of patients with pain, licensed and practicing in the State, nominated by the Maryland Society of Physical Medicine and Rehabilitation;
(6)
Two medical professionals, licensed and practicing in the State with expertise or experience in providing care for patients with substance–related or mental health disorders;
(7)
A dentist licensed and practicing in the State; and
(8)
A medical professional licensed and practicing in the State in the field of internal medicine or family practice.